Skip to main content
Insight Brief

Decentralization: An Ethical Obligation

For more than 60 years, the traditional clinical trial model has relied on a disparate network of independent investigator sites to find, enroll, and matriculate patients through a study to determine drug efficacy and safety. This same model has been shown to exclude more than 90% of patients from participating. Whilst, less than 3% of all healthcare providers participate as clinical trial investigators.


Today, we live in a world where we have the capability to reach anyone, anywhere utilizing decentralized clinical trial techniques and more agile clinical trial designs, and we have an ethical obligation to implement them. 


Interested in learning more? Download the full insight brief from David Coman.